ARCHIVES

NCI Offers Bibliography On Risk Communication.

This article is from The Cancer Letter archive.

Vol. 27 No. 12 | March 23, 2001

Download PDF Visit The Full Archive

Related Articles

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

DFCI Puts The Cancer Letter On Its Intranet For Employees.

February 11, 2000

FDA Approves New Indication For Anticoagulant Frangmin

May 25, 2007

Prostatectomy Lowers Death Risk Compared to Watchful Waiting

April 29, 2011

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

August 26, 2005

DCT Will Consider Planning, Center Core Supplemental, Program Project Grants In $5 Million Surgical Oncology Development Effort

October 10, 1980